Immutep Announces Australian Patent Granted for Eftilagimod Alpha in Chemo-Immunotherapy

Thursday, June 20, 2019 1 min read

Key Takeaway: Immutep Announces Australian Patent Granted for Eftilagimod Alpha in Chemo-Immunotherapy

Full Press Release Details

Immutep Announces Australian Patent Granted for Eftilagimod Alpha in Chemo-Immunotherapy.